Stryker (SYK) Stock Forecast & Price Target

Compare

2,408 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SYK Analyst Ratings

Strong Buy

15 Buy

2 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Stryker

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SYK Stock 12 Month Forecast

Average Price Target

$433.44

▲(13.14%Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $433.44 with a high forecast of $465.00 and a low forecast of $390.00. The average price target represents a 13.14% change from the last price of $383.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"324":"$324","395":"$395","466":"$466","359.5":"$359.5","430.5":"$430.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":465,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$465.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":433.44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$433.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":390,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$390.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[324,359.5,395,430.5,466],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,373.99,380.9907692307692,387.9915384615385,394.9923076923077,401.99307692307696,408.99384615384616,415.9946153846154,422.99538461538464,429.99615384615385,436.99692307692305,443.9976923076923,450.9984615384615,457.9992307692308,{"y":465,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,373.99,378.56307692307695,383.13615384615383,387.70923076923077,392.2823076923077,396.8553846153846,401.42846153846153,406.0015384615385,410.5746153846154,415.1476923076923,419.72076923076924,424.2938461538462,428.86692307692306,{"y":433.44,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,373.99,375.22153846153844,376.45307692307694,377.68461538461537,378.91615384615386,380.1476923076923,381.3792307692308,382.6107692307692,383.8423076923077,385.07384615384615,386.30538461538464,387.5369230769231,388.76846153846157,{"y":390,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":325.11,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":337.96,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":334.2,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.9,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":357.96,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.62,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":365.45,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":387.83,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":359.22,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":390.39,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":385.3,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":373.3,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":373.99,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$465.00

Average Price Target$433.44

Lowest Price Target$390.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matt MiksicBarclays

Barclays

$443

Buy

15.64%

Upside

Reiterated

05/29/25

Barclays Keeps Their Buy Rating on Stryker (SYK)

Joanne WuenschCiti

Citi

$443→$455

Buy

18.77%

Upside

Reiterated

05/23/25

Stryker price target raised to $455 from $443 at CitiStryker price target raised to $455 from $443 at Citi

Travis SteedBank of America Securities

Bank of America Securities

―

Buy

―

Reiterated

05/15/25

Stryker (SYK) Gets a Buy from Bank of America Securities

Richard NewitterTruist Financial

Truist Financial

$390→$400

Hold

4.41%

Upside

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Cerus (NASDAQ: CERS), Stryker (NYSE: SYK) and Praxis Precision Medicines (NASDAQ: PRAX)

Danielle AntalffyUBS

UBS

$405→$421

Hold

9.89%

Upside

Reiterated

05/05/25

Stryker (SYK) PT Raised to $421 at UBSUBS analyst Danielle Antalffy raised the price target on Stryker (NYSE: SYK) to $421.00 (from $405.00) while maintaining a Neutral rating.

Caitlin CroninCanaccord Genuity

Canaccord Genuity

$435

Buy

13.55%

Upside

Reiterated

05/05/25

Stryker's Strategic Moves and Strong Financial Outlook Justify Buy Rating with $435 Price Target

Lee HambrightBernstein

Bernstein

$450

Buy

17.46%

Upside

Reiterated

05/04/25

Stryker's Strong Performance and Growth Potential Justify Buy Rating

Matthew TaylorJefferies

Jefferies

$465

Buy

21.38%

Upside

Reiterated

05/02/25

Stryker's Strong Financial Performance and Strategic Positioning Justify Buy Rating

Josh JenningsTD Cowen

TD Cowen

$435

Buy

13.55%

Upside

Reiterated

05/02/25

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY) and Stryker (NYSE: SYK)

Jason WittesRoth MKM

Roth MKM

$405→$456

Buy

19.03%

Upside

Reiterated

05/02/25

Roth MKM Sticks to Their Buy Rating for Stryker (SYK)

Rick WiseStifel Nicolaus

Stifel Nicolaus

$440

Buy

14.85%

Upside

Reiterated

05/02/25

Stifel Nicolaus Sticks to Its Buy Rating for Stryker (SYK)

Vijay KumarEvercore ISI

Evercore ISI

$400→$390

Buy

1.80%

Upside

Reiterated

05/02/25

Stryker (SYK) PT Lowered to $390 at Evercore ISIEvercore ISI analyst Vijay Kumar lowered the price target on Stryker (NYSE: SYK) to $390.00 (from $400.00) while maintaining a Outperform rating.

Shagun Singh ChadhaRBC Capital

RBC Capital

$435

Buy

13.55%

Upside

Reiterated

05/02/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Exact Sciences (NASDAQ: EXAS), 89bio (NASDAQ: ETNB) and Stryker (NYSE: SYK)

Matthew O'BrienPiper Sandler

Piper Sandler

$420

Buy

9.63%

Upside

Reiterated

05/02/25

Piper Sandler Sticks to Its Buy Rating for Stryker (SYK)

Ryan ZimmermanBTIG

BTIG

$403

Buy

5.19%

Upside

Reiterated

05/02/25

Analysts Offer Insights on Healthcare Companies: Stryker (NYSE: SYK), Arvinas Holding Company (NASDAQ: ARVN) and Ardelyx (NASDAQ: ARDX)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matt MiksicBarclays

Barclays

$443

Buy

15.64%

Upside

Reiterated

05/29/25

Barclays Keeps Their Buy Rating on Stryker (SYK)

Joanne WuenschCiti

Citi

$443→$455

Buy

18.77%

Upside

Reiterated

05/23/25

Stryker price target raised to $455 from $443 at CitiStryker price target raised to $455 from $443 at Citi

Travis SteedBank of America Securities

Bank of America Securities

―

Buy

―

Reiterated

05/15/25

Stryker (SYK) Gets a Buy from Bank of America Securities

Richard NewitterTruist Financial

Truist Financial

$390→$400

Hold

4.41%

Upside

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Cerus (NASDAQ: CERS), Stryker (NYSE: SYK) and Praxis Precision Medicines (NASDAQ: PRAX)

Danielle AntalffyUBS

UBS

$405→$421

Hold

9.89%

Upside

Reiterated

05/05/25

Stryker (SYK) PT Raised to $421 at UBSUBS analyst Danielle Antalffy raised the price target on Stryker (NYSE: SYK) to $421.00 (from $405.00) while maintaining a Neutral rating.

Caitlin CroninCanaccord Genuity

Canaccord Genuity

$435

Buy

13.55%

Upside

Reiterated

05/05/25

Stryker's Strategic Moves and Strong Financial Outlook Justify Buy Rating with $435 Price Target

Lee HambrightBernstein

Bernstein

$450

Buy

17.46%

Upside

Reiterated

05/04/25

Stryker's Strong Performance and Growth Potential Justify Buy Rating

Matthew TaylorJefferies

Jefferies

$465

Buy

21.38%

Upside

Reiterated

05/02/25

Stryker's Strong Financial Performance and Strategic Positioning Justify Buy Rating

Josh JenningsTD Cowen

TD Cowen

$435

Buy

13.55%

Upside

Reiterated

05/02/25

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY) and Stryker (NYSE: SYK)

Jason WittesRoth MKM

Roth MKM

$405→$456

Buy

19.03%

Upside

Reiterated

05/02/25

Roth MKM Sticks to Their Buy Rating for Stryker (SYK)

Rick WiseStifel Nicolaus

Stifel Nicolaus

$440

Buy

14.85%

Upside

Reiterated

05/02/25

Stifel Nicolaus Sticks to Its Buy Rating for Stryker (SYK)

Vijay KumarEvercore ISI

Evercore ISI

$400→$390

Buy

1.80%

Upside

Reiterated

05/02/25

Stryker (SYK) PT Lowered to $390 at Evercore ISIEvercore ISI analyst Vijay Kumar lowered the price target on Stryker (NYSE: SYK) to $390.00 (from $400.00) while maintaining a Outperform rating.

Shagun Singh ChadhaRBC Capital

RBC Capital

$435

Buy

13.55%

Upside

Reiterated

05/02/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Exact Sciences (NASDAQ: EXAS), 89bio (NASDAQ: ETNB) and Stryker (NYSE: SYK)

Matthew O'BrienPiper Sandler

Piper Sandler

$420

Buy

9.63%

Upside

Reiterated

05/02/25

Piper Sandler Sticks to Its Buy Rating for Stryker (SYK)

Ryan ZimmermanBTIG

BTIG

$403

Buy

5.19%

Upside

Reiterated

05/02/25

Analysts Offer Insights on Healthcare Companies: Stryker (NYSE: SYK), Arvinas Holding Company (NASDAQ: ARVN) and Ardelyx (NASDAQ: ARDX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Stryker

1 Month

xxx

Success Rate

17/23 ratings generated profit

Average Return

+4.54%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 73.91% of your transactions generating a profit, with an average return of +4.54% per trade.

3 Months

xxx

Success Rate

18/23 ratings generated profit

Average Return

+5.82%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 78.26% of your transactions generating a profit, with an average return of +5.82% per trade.

1 Year

Shagun Singh ChadhaRBC Capital

Success Rate

17/18 ratings generated profit

Average Return

+14.53%

reiterated a buy rating last month

Copying Shagun Singh Chadha's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +14.53% per trade.

2 Years

xxx

Success Rate

23/23 ratings generated profit

Average Return

+29.44%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +29.44% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SYK Analyst Recommendation Trends

Rating

Jan 25

Feb 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SYK has received 26 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. SYK average Analyst price target in the past 3 months is 433.44.

Each month's total comprises the sum of three months' worth of ratings.

SYK Financial Forecast

SYK Earnings Forecast

Next quarter’s earnings estimate for SYK is $3.07 with a range of $3.00 to $3.15. The previous quarter’s EPS was $2.84. SYK beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year SYK has Outperformed its overall industry.

SYK Sales Forecast

Next quarter’s sales forecast for SYK is $5.93B with a range of $5.75B to $6.13B. The previous quarter’s sales results were $5.87B. SYK beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year SYK has Outperformed its overall industry.

SYK Stock Forecast FAQ

What is SYK’s average 12-month price target, according to analysts?

Based on analyst ratings, Stryker Corporation’s 12-month average price target is 433.44.

What is SYK’s upside potential, based on the analysts’ average price target?

Stryker Corporation has 13.14% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SYK a Buy, Sell or Hold?

Stryker Corporation has a consensus rating of Strong Buy which is based on 15 buy ratings, 2 hold ratings and 0 sell ratings.

What is Stryker Corporation’s price target?

The average price target for Stryker Corporation is 433.44. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $465.00 ,the lowest forecast is $390.00. The average price target represents 13.14% Increase from the current price of $383.1.

What do analysts say about Stryker Corporation?

Stryker Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of SYK?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Stryker (SYK) Stock Forecast & Price Target

SYK Analyst Ratings

SYK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Stryker

SYK Analyst Recommendation Trends

SYK Financial Forecast

SYK Earnings Forecast

SYK Sales Forecast

SYK Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts